earnings
confidence high
sentiment positive
materiality 0.70
Select Medical Q3 revenue $1.67B (+6.2%), EPS $0.38 (+75.8%), maintains FY outlook
SELECT MEDICAL HOLDINGS CORP
2023-Q3 EPS reported
$1.55
revenue$5,005,202,000
- Q3 revenue $1,665.7M (+6.2% YoY); net income $60.8M (+59.5%).
- Q3 adjusted EBITDA $193.8M (+26.6%); adjusted EPS $0.46 (+113.7%).
- Critical illness recovery hospital segment Adjusted EBITDA surged 321% to $46.4M.
- FY 2023 outlook maintained: revenue $6.55B-$6.7B, Adj. EBITDA $795M-$825M, EPS $1.77-$1.94.
- Board declared $0.125/share dividend payable Nov 28; $1.0B stock repurchase program authorized.